Form 4: Aquestive Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Daniel Barber, President and CEO of Aquestive Therapeutics, Inc., sold 25,000 shares of common stock on July 15, 2026.
Summary
- Open-market sale: disposed of 4,631 Common Stock at $4.03 ($18,683) on July 15, 2026; holds 630,943 after (Direct).
- Open-market sale: disposed of 20,369 Common Stock at $4.00 ($81,509) on July 16, 2026; holds 610,574 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $100,192 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Daniel Barber — Officer (President and CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Open-market sale | Common Stock | 4,631 | $4 | $18.7K | 630,943 |
| 2026-07-16 | Open-market sale | Common Stock | 20,369 | $4 | $81.5K | 610,574 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Open-market sale (4,631 shares) |
| 2026-07-16 | Open-market sale (20,369 shares) |
Keywords
insider transaction, Form 4, AQST, Aquestive Therapeutics, Inc., bearish, Daniel Barber
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.